发明授权
- 专利标题: 2-heteroaryl substituted benzothiophenes and benzofuranes 709
- 专利标题(中): 2-杂芳基取代的苯并噻吩和苯并呋喃709
-
申请号: US12042795申请日: 2008-03-05
-
公开(公告)号: US07772256B2公开(公告)日: 2010-08-10
- 发明人: Erwan Arzel , Britt-Marie Swahn , David Wensbo
- 申请人: Erwan Arzel , Britt-Marie Swahn , David Wensbo
- 申请人地址: SE Sodertalje
- 专利权人: Astrazeneca AB
- 当前专利权人: Astrazeneca AB
- 当前专利权人地址: SE Sodertalje
- 代理商 John A. Cleveland, Jr.
- 主分类号: A61K31/443
- IPC分类号: A61K31/443 ; C07D405/04
摘要:
The present invention relates to novel 2-heteroaryl substituted benzothiophene and benzofuran derivatives, precursors thereof, and therapeutic uses of such compounds, having the structural formula (Ia) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel 2-heteroaryl substituted benzothiophene and benzofuran derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.
公开/授权文献
信息查询
IPC分类: